Still time to apply 👉 #ESMOPreceptorship on Metastatic #BladderCancer & #KidneyCancer : molecular pathology & diagnosis as contributing factors to heterogeneity, assessment & multidisciplinary tx, advances in tx & novel targets
🔗 ow.ly/FZeH50QBJBl
#blcsm #kcsm Laurence Albiges

Proud of Gustave Roussy GU group celebrating 20th anniversary #GU24 🎂
Thrilled to contribute to 20years of advances in GU cancers care !

Missing Pierre Blanchard, MD Alberto Bossi Christophe Massard

The #MCCRWorkshop enables peer #mentoring and #CareerDevelopment for early-career #oncology professionals. Apply now to gain access to mentors and develop protocols ready for submission.
⏲️ Deadline: 1 February 2024.
ow.ly/m7TG50QtYnF
EORTC AACR #CancerResearch

Listening to 'December 2023 – Eur Urol Oncology highlights' at buzzsprout.com/2220728/142769… European Urology Oncology European Association of Urology (EAU) Ashish M. Kamat, MD, MBBS Riccardo Campi Cathy Elena Castro Alicia Morgans, MD, MPH Ploussard Guillaume Jeremy Teoh Laurence Albiges Declan Murphy

JUST IN: U.S. FDA approved belzutifan (HIF2 inhibitor) in advanced renal cell carcinoma (RCC) following PD1 and VEGF inhibitors!

A great day for the field and a new option for our Kidney Cancer patients!!!!

Via ASCO #FDAAlerts OncoAlert

Study presented at ESMO - Eur. Oncology #ESMO3 by…

Starting shortly #ESMOIO23 full #GU session on hot topic in #IO all stars ⭐️ panel
Guillermo de Velasco
Bernard-Tessier Gustave Roussy
Tom Powles Uromigos
Pignot Géraldine Institut Paoli-Calmettes (IPC) GETUG Unicancer Association Française d'Urologie - AFU

Do not miss ESMO - Eur. Oncology !

#ESMOAsia23 GU educational on perioperative therapy chairs Deborah Mukherji Ravindran Kanesvaran
Excellent Enrique Grande making clear neoadj/adj landscape in UC!
Content available here tomorrow:
oncologypro.esmo.org/meeting-resour…

Fantastic discussion Deborah Mukherji #ESMOAsia23 highlighting
(1) higher de novo M+ disease in HSPC in Asia: 10% higher in recent ARASENS Chinese substudy
(2) lower rate of intensification therapy in mHSPC Advanced Prostate Cancer Consensus Conference Lisa Pickering 💉💙 Enrique Grande ESMO - Eur. Oncology Christopher Sweeney, MBBS Uromigos

#pragmatic #ESMOAsia23 Low dose IO including de-escalation strategy… pending prospective trials PULSE Benjamin Besse Gustave Roussy in NSCLC and MOIO Dr Gravis Institut Paoli-Calmettes (IPC) across tumor type GETUG Unicancer

Watch below for a message from Dr. David McDermott for Tonight's Symposium! Join the #RCC experts, Sumanta K. Pal, MD, FASCO, Laurence Albiges, and David F. McDermott, MD, for a live educational event tonight, Friday, November 10, at 6:45 pm CST during #IKCSNA23 ! bit.ly/Nashville23T #MedEd

Cancers du rein et des voies urinaires : nouvelles stratégies thérapeutiques présentées à l' #ESMO2023
Avec Laurence Albiges et Constance Thibault
Gustave Roussy Hôpital européen Georges-Pompidou AP-HP
ms.spr.ly/60149hIFE

The #ESMO23 congress provided updates from multiple trials for the treatment of renal cell carcinoma (RCC)

How is this emerging data likely to impact clinical practice?

Find out in our review with expert Laurence Albiges: cor2ed.com/gu-connect/pro…

#MedEd #RCC Laurence Albiges

The #ESMO23 Highlight videos series - daily interviews with selected LBA presenters.🔗ow.ly/xJ6250Q1rSA
With Laurence Albiges, Yelena Y. Janjigian MD, Ben Solomon, Herbert Loong, Michiel van der Heijden, Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ, Domenica Lorusso, Julien Hadoux, Filippo Pietrantonio, Funda Meric-Bernstam, Aaron…

Hone your ability to develop treatment strategies for patients with #RCC by joining a symposium featuring Drs. Sumanta Kumar Pal (Sumanta K. Pal, MD, FASCO), Prof. Laurence Albiges (@AlbigesL), & David F. McDermott. 11/10 at 6:45 PM CST during #IKCSNA23 : bit.ly/Nashville23T #MedEd

#ESMO23 : Over 3,400 slides, webcasts, abstracts & ePosters are now available on OncologyPRO 👉 practice-changing data and state-of-the-art educational content from more than 20 tracks.
ow.ly/9sNL50Q5QFn

#MedTwitter #OncTwitter

Rule clarification.The photo with the most ‘likes’ by Friday wins. If you want to support someone else you can post a photo, and say in the text who you are supporting instead of yourself. We then add up the likes. Top 2 go into a vote run off if it’s close Shilpa Gupta Toni Choueiri, MD

ESMO has announced the recipients of the 2023 ESMO Society Awards based on recognition of their work in strengthening the oncology field and providing support to fellow oncologists in their professional careers.
📌ow.ly/rvam50PgY7U

Just out in JAMA Oncology NIVOREN Gustave Roussy ancillary study  Félix Lefort Corticosteroids use impact in pts with mRCC under nivolumab: longer PFS&OS - 2 potential explanations (i)steroid mainly for IrAEs, selected stronger immune response (ii)persistent signif. immortal time bias